To address these discrepancies, we sought to determine the prevalence of AR-V7 and AR-v567es expression by analyzing large publicly available RNA sequencing data sets of primary prostate cancer (TCGA) and mCRPC (SU2C- PCF Dream Team). This evidence concerns the gene AR and prostate carcinoma.